(travoprost + timolol)
eye drops (0.04 mg + 5 mg)/mL
In a voluminous economical packaging 5 mL
Combined antiglaucoma preparation containing a prostaglandin analogue and a beta-blocker.
It has the most pronounced hypotensive effect among all fixed combinations, combined with an antioxidant effect and improvement of ophthalmic hemodynamics.
• Non-toxic to the cornea
• Does not cause eye burning and irritation
• Does not lead to the development of dry eye syndrome
- Characterized by high efficiency and safety
- Produced in a special innovative packaging that ensures the sterility of the drug throughout the entire period of use
- Can be used within 3 months after opening the package